Attenuation of reperfusion microvascular ischemia by aqueous oxygen: Experimental and clinical observations

American Heart Journal

Volumn 149, Issue 4, 2005, Pages 580-584

  Glazier, James J ^a  

^a HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ADENOSINE; BLOOD CLOTTING FACTOR 7A INHIBITOR; COMPLEMENT RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; FIBRINOGEN RECEPTOR ANTAGONIST; LEUKOCYTE ANTIBODY; NICORANDIL; OXYGEN; PAPAVERINE; RECEPTOR BLOCKING AGENT; VERAPAMIL;

ACUTE HEART INFARCTION; ARTERY OCCLUSION; ARTICLE; CATHETER; CLINICAL TRIAL; CONVALESCENCE; CORONARY ARTERY BLOOD FLOW; CORONARY STENT; CRYSTALLOID; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERBARIC OXYGEN; METHODOLOGY; MICROANGIOPATHY; MICROVASCULAR ISCHEMIA; NONHUMAN; OXYGEN THERAPY; PRIORITY JOURNAL; RECANALIZATION; REPERFUSION INJURY; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 17044432990     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.12.009     Document Type: Review

References (26)

1. S.H. Rezkalla, and R.A. Kloner No reflow phenomenon Circulation 105 2002 656 662
2. T. Reffelmann, and R.A. Kloner The "no-reflow" phenomenon: basic science and clinical correlates Heart 87 2002 162 168
3. D.E. Kandzari, and J.E. Tcheng Double negatives Am. Heart J. 145 2003 9 12
4. R.A. Kloner, and W. Dai Glycoprotein IIb/IIIa inhibitors and no-reflow J. Am. Coll. Cardiol. 43 2004 284 286
5. R. Bolli, J.F. Triana, and M.O. Jeroudi Prolonged impairment of coronary vasodilation after reversible ischemia. Evidence for microvascular "stunning" Circ. Res. 67 1990 332 343
6. L. Maxwell, and J.B. Gavin The contribution of ischemia to the development of microvascular incompetence in the myocardium Cardiovasc. Res. 25 1991 491 495
7. R.A. Kloner, C.E. Ganote, and R.B. Jennings The "no reflow" phenomenon after temporary coronary occlusion in the dog J. Clin. Invest. 54 1974 1496 1508
8. H. Ito, T. Tomooka, and N. Sakai Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction Circulation 85 1992 1699 1705
9. M.J. Claeys, J. Bosmans, and L. Veenstra Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome Circulation 99 1999 1972 1977
10. K.C. Wu, E.A. Zerhouni, and R.M. Judd Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction Circulation 97 1998 765 772
11. C.M. Gibson, C.P. Cannon, and S.A. Murphy Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs Circulation 101 2000 125 130
12. C.D. Rochitte, J.A. Lima, and D.A. Bluemke Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction Circulation 98 1998 1006 1014
13. F.J. Neumann, R. Blasini, and C. Schmitt Effect of lipoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary artery stents in acute myocardial infarction Circulation 98 1998 2695 2701
14. J.A. de Lemos, E.M. Antman, and M. Gibson Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction: observations from the TIMI 14 trial Circulation 101 2000 239 243
15. S. Ogawa, H. Gerlach, and C. Esposito Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium increased monolayer permeability and induction of procoagulant properties J. Clin. Invest. 85 1990 1090 1098
16. I. Ginis, S.J. Mentzer, and X. Li Characterization of a hypoxia responsive adhesion molecule for leukocytes on human endothelial cells J. Immunol. 155 1995 802 810
17. N. Baudry, G. Danialou, and J. Boczkowski In vivo study of the effect of systemic hypoxia on leukocyte-endothelium interaction Am. J. Respir. Crit. Care Med. 158 1998 477 483
18. H.S. Cha, K.S. Ahn, and C.H. Jeon Influence of hypoxia on the expression of matrix metalloproteinases-1, -3 and tissue inhibitor of metalloproteinases-1 in rheumatoid synovial fibroblasts Clin. Exp. Rheumatol. 21 2003 593 598
19. A.J.V. Cameron, L. Hutton, and A.C.F. Kenmure Haemodynamic and metabolic effects of hyperbaric oxygen in myocardial infarction Lancet 2 1966 833 837
20. D.L. Sterling, J.D. Thornton, and A. Swafford Hyperbaric oxygen limits infarct size in ischemic rabbit myocardium in vivo Circulation 88 1993 1931 1936
21. M.P. Thomas, L.A. Brown, and D.R. Sponseller Myocardial infarct size reduction by the synergistic effect of hyperbaric oxygen and recombinant tissue plasminogen activator Am. Heart J. 120 1990 791 800
22. Spears JR. Method and apparatus for delivering oxygen into blood. U.S. Patent No. 5,407,426. 1995.
23. 2-supersaturated infusate for regional correction of hypoxemia and production of hyperoxemia Circulation 96 1997 4385 4391
24. J.R. Spears, C. Henney, and P. Prcevski Aqueous oxygen hyperbaric reperfusion in a porcine model of myocardial infarction J. Invasive Cardiol. 14 2002 160 166
25. J.R. Spears, P. Prcevski, and R. Xu Aqueous oxygen attenuation of reperfusion micro vascular ischemia in a canine model of myocardial infarction ASAIO J. 49 2003 716 720
26. S.R. Dixon, A.L. Bartorelli, and P.A. Marcovitz Initial experience with hyperoxemic reperfusion after primary angioplasty for acute myocardial infarction. Results of a pilot study utilizing intracoronary aqueous oxygen therapy J. Am. Coll. Cardiol. 39 2002 387 392